Periods Groups | Body weights (g) | Body weight gains (g) | ||||
---|---|---|---|---|---|---|
At OVX [A]* | At 34Â days after OVX [B] | At initial treatment [C]* | At sacrifice [D]* | OVX recovery [B-A] | Treatment [D-C] | |
Controls | ||||||
 Sham | 25.55 ± 1.62 | 33.86 ± 2.53 | 29.90 ± 2.56 | 31.45 ± 2.74 | 8.31 ± 1.88 | 1.46 ± 0.92 |
 OVX | 25.51 ± 1.20 | 37.40 ± 3.22b | 33.96 ± 2.84a | 37.59 ± 2.75a | 11.89 ± 2.90a | 3.63 ± 0.73a |
Reference (2.5Â mg/kg) | ||||||
 RES | 26.29 ± 0.80 | 36.68 ± 1.71b | 33.40 ± 1.68b | 35.75 ± 2.80a | 10.39 ± 1.53b | 2.35 ± 2.11 |
Single formula (200Â mg/kg) | ||||||
 EAP | 26.61 ± 1.59 | 37.70 ± 3.22a | 34.00 ± 2.62a | 35.08 ± 1.90a | 11.09 ± 3.11b | 1.08 ± 1.76c |
 TM | 25.99 ± 1.35 | 37.31 ± 3.20b | 34.10 ± 2.99a | 35.06 ± 2.57a | 11.33 ± 2.55 a | 0.96 ± 0.78c |
Mixed formula - EAP:TM (200Â mg/kg) | ||||||
 1:1 | 25.60 ± 1.82 | 36.59 ± 1.87 | 33.18 ± 1.83b | 34.53 ± 2.11bd | 10.99 ± 2.10a | 1.35 ± 1.47c |
 1:3 | 26.80 ± 2.21 | 37.63 ± 3.03a | 34.26 ± 2.74a | 35.24 ± 3.58a | 10.83 ± 2.29b | 0.98 ± 1.41c |
 1:5 | 25.60 ± 1.01 | 37.58 ± 2.92b | 33.80 ± 2.63a | 34.69 ± 3.91bd | 11.98 ± 3.34a | 0.89 ± 2.03c |
 1:7 | 26.73 ± 1.88 | 37.49 ± 2.95b | 33.84 ± 2.53a | 34.91 ± 2.49b | 10.79 ± 2.27b | 1.08 ± 2.23c |
 1:9 | 26.39 ± 1.14 | 37.55 ± 2.98b | 34.08 ± 2.67a | 35.23 ± 1.75a | 11.16 ± 2.53a | 1.15 ± 1.73c |
 3:1 | 25.93 ± 1.27 | 37.51 ± 2.99b | 33.79 ± 2.76a | 32.76 ± 2.66c | 11.59 ± 2.83a | - 1.03 ± 1.43acef |
 5:1 | 26.13 ± 1.24 | 37.54 ± 2.87b | 34.00 ± 2.75a | 34.99 ± 2.52b | 11.41 ± 3.27a | 0.99 ± 1.92c |
 7:1 | 26.11 ± 0.96 | 37.48 ± 2.89b | 33.96 ± 2.69a | 34.91 ± 3.10b | 11.36 ± 2.62a | 0.95 ± 1.25c |
 9:1 | 26.44 ± 1.66 | 37.50 ± 2.80b | 34.05 ± 2.79a | 35.05 ± 2.15a | 11.06 ± 2.50a | 1.00 ± 1.71c |